SCHEMBL30674433

SCHEMBL30674433

CC1(C)OB(c2ccc(Nc3ccc4c(c3)oc3ccccc34)cc2)OC1(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LPL P06858 2/20 0.44
▸ LIPG Q9Y5X9 2/20 0.44
▸ SMN1; SMN2 Q16637 6/20 0.44
▸ NPC1 O15118 6/20 0.44
▸ RAB9A P51151 6/20 0.44
▸ MEN1 O00255 6/20 0.44
▸ KMT2A Q03164 6/20 0.44
▸ GAA P10253 3/20 0.44
▸ ALDH1A1 P00352 5/20 0.42
▸ LMNA P02545 4/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA3 P07451 1/20 0.42
▸ CA4 P22748 1/20 0.42
▸ CA6 P23280 1/20 0.42
▸ CA5A P35218 1/20 0.42
▸ CA7 P43166 1/20 0.42
▸ CA9 Q16790 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29925432 0.84 LPL (0.49) LPLLIPGSMN1; SMN2NPC1RAB9A
SCHEMBL31158057 0.84 LPL (0.49) LPLLIPGSMN1; SMN2NPC1RAB9A
SCHEMBL484105 0.84 LPL (0.49) LPLLIPGSMN1; SMN2NPC1RAB9A
SCHEMBL29831860 0.82 LIPG (0.59) LPLLIPGNPC1RAB9AMEN1
SCHEMBL18090640 0.82 LIPG (0.59) LPLLIPGNPC1RAB9AMEN1
SCHEMBL22737977 0.80 LIPG (0.51) LPLLIPGMEN1KMT2AALDH1A1
SCHEMBL17283499 0.80 KMT2A (0.60) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL20321608 0.79 LPL (0.46) LPLLIPGSMN1; SMN2NPC1RAB9A
SCHEMBL21819707 0.79 LPL (0.44) LPLLIPGMEN1KMT2AALDH1A1
SCHEMBL2037575 0.79 LPL (0.49) LPLLIPGSMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240059705-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2024-02-22 — — US disclosed
US-11814395-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11814395-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, MCM4 LPL 1919/4885LIPG 2338/4885SMN1; SMN2 4634/4885
US-20240059705-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, MCM4 LPL 1919/4885LIPG 2338/4885SMN1; SMN2 4634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback